<p>
Kane Miller, CEO of Axitan, discusses novel antibacterial enzymes known as endolysins, which his company has developed to target Clostridium perfringens and other pathogens.</p>
<p>




</p>

Kane Miller, CEO of Axitan, discusses novel antibacterial enzymes known as endolysins, which his company has developed to target Clostridium perfringens and other pathogens.

Novel enzymes target Clostridium perfringens

Podcasts focused on animal nutrition best practices, feed industry trends and offbeat agriculture news relevant to the global animal feed industry.

Share Novel enzymes target Clostridium perfringens

Sign up to save your podcasts

Novel enzymes target Clostridium perfringens

Novel enzymes target Clostridium perfringens

More shows like Feed Strategy Podcasts

Marketplace

Up First from NPR